Construct: ORF ccsbBroadEn_14526
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF019023.1_s300c1, BRDN0000458641
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- ABL2 (27)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | XM_005245088.2 | 100% | 100% | |
| 2 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_005158.5 | 98.2% | 98.2% | 110_172del |
| 3 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_001168236.2 | 97.1% | 95.5% | (many diffs) |
| 4 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | XM_017001035.1 | 94.9% | 93.7% | (many diffs) |
| 5 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_007314.4 | 94.5% | 94.1% | (many diffs) |
| 6 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_001168239.2 | 91% | 91% | 1950_1951ins309 |
| 7 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_001136000.3 | 89.3% | 89.3% | 110_172del;2013_2014ins309 |
| 8 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_001168238.2 | 88.3% | 86.7% | (many diffs) |
| 9 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_001168237.2 | 85.9% | 85.4% | (many diffs) |
| 10 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | XR_921765.1 | 46.3% | (many diffs) | |
| 11 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | XR_921764.3 | 45.2% | (many diffs) | |
| 12 | human | 27 | ABL2 | ABL proto-oncogene 2, non-r... | NM_001136001.1 | 43.7% | 41.6% | (many diffs) |
| 13 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496617.3 | 89.4% | 93.3% | (many diffs) |
| 14 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496614.3 | 88% | 91.7% | (many diffs) |
| 15 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496613.3 | 87.9% | 91.7% | (many diffs) |
| 16 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496616.3 | 87.4% | 90.4% | (many diffs) |
| 17 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496615.3 | 87.3% | 90.3% | (many diffs) |
| 18 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_011238737.2 | 85.4% | 89.2% | (many diffs) |
| 19 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | NM_009595.3 | 85.4% | 89.1% | (many diffs) |
| 20 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496622.3 | 81.1% | 85.2% | (many diffs) |
| 21 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496620.3 | 79.8% | 83.7% | (many diffs) |
| 22 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_006496621.3 | 79.2% | 82.3% | (many diffs) |
| 23 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | XM_011238738.2 | 77.4% | 81.2% | (many diffs) |
| 24 | mouse | 11352 | Abl2 | v-abl Abelson murine leukem... | NM_001136104.1 | 77.4% | 81.2% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 3507
- ORF length:
- 3438
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaactttg tacaaaaaag 61 ttggcaccat ggtccttggg acagttctcc ttccacctaa tagttatggc agagatcagg 121 acacttcact ttgctgcctg tgcactgagg cctcagaatc tgctctaccc gacttaacag 181 aagctttgca tcgtccctat ggttgtgatg ttgaacccca ggcactaaat gaggctatca 241 ggtggagctc caaggagaac ttgctcggag ccactgagag tgaccctaat ctcttcgttg 301 cactttatga ttttgtagca agtggtgata acacactcag catcactaaa ggtgaaaagc 361 tacgagtcct tggttacaac cagaatggtg agtggagtga agttcgctct aagaatgggc 421 agggctgggt gccaagcaac tacatcaccc cagtgaacag cctggaaaaa cactcctggt 481 accatggacc tgtgtcacgc agtgcagctg agtatctgct cagcagtcta atcaatggca 541 gcttcctggt gcgagaaagt gagagtagcc ctgggcagct gtccatctcg ctcaggtacg 601 agggacgtgt gtatcactac aggatcaata ccactgcaga tggcaaggtg tatgtgactg 661 ctgagagccg cttcagcacc ttggcagagc ttgtacacca tcactccaca gtggctgatg 721 ggctggtgac aacattacac tacccagcac ccaagtgtaa taagcctaca gtctatggtg 781 tgtcccccat ccacgacaaa tgggaaatgg agcgaacaga tattaccatg aagcacaaac 841 ttgggggcgg tcagtatgga gaggtttacg ttggcgtctg gaagaaatac agccttacag 901 ttgctgtgaa aacattgaag gaagatacca tggaggtaga agaattcctg aaagaagctg 961 cagtaatgaa ggaaatcaag catcctaatc tggtacaact tttaggtgtg tgtactttgg 1021 agccaccatt ttacattgtg actgaataca tgccatacgg gaatttgctg gattacctcc 1081 gagaatgcaa ccgagaagag gtgactgcag ttgtgctgct ctacatggcc actcagattt 1141 cttctgcaat ggagtactta gagaagaaga atttcatcca tagagatctt gcagctcgta 1201 actgcctagt gggagaaaac catgtggtaa aagtggctga ctttggctta agtagattga 1261 tgactggaga cacttatact gctcatgctg gagccaaatt tcctattaag tggacagcac 1321 cagagagtct tgcctacaat accttctcaa ttaaatctga cgtctgggct tttggggtat 1381 tgttgtggga aattgctacc tatggaatgt caccatatcc aggtattgac ctgtctcagg 1441 tctatgacct actagaaaaa ggatatcgaa tggaacagcc tgagggatgc ccccctaagg 1501 tttatgaact tatgagagca tgctggaagt ggagccctgc cgataggccc tcttttgctg 1561 aaacacacca agcttttgaa accatgttcc atgactccag catttctgaa gaggtagctg 1621 aggagcttgg gagagccgcc tcctcgtcat ctgttgttcc atacctgccc cggctaccta 1681 tacttccttc caagactcgg acactgaaga aacaggtgga gaacaaggag aacattgaag 1741 gggcacaaga tgccacagaa aattctgctt ccagtttagc accagggttc atcagaggtg 1801 cacaggcctc tagtggatcc ccagcactgc ctcgaaagca aagagacaag tcacccagca 1861 gcctcttgga agatgccaaa gagacatgct tcaccaggga taggaagggg ggcttcttca 1921 gctccttcat gaagaagaga aatgctccta caccccccaa acgcagcagc tccttccgag 1981 aaatggagaa tcagccccat aagaaatacg aactcacggg taacttctca tctgttgctt 2041 ctctacagca tgctgatggg ttctctttca ctcctgccca gcaagaggcg aatctggtgc 2101 cacccaagtg ctatgggggg agctttgcac agaggaacct ctgtaatgac gacggtggtg 2161 ggggtggggg cagtggcact gctgggggtg ggtggtctgg catcacaggc ttctttacac 2221 cacgcttaat caaaaagaca ctgggcttac gagcaggtaa acccacagcc agtgatgaca 2281 cttccaagcc ttttccaagg tcaaactcta catcttccat gtcctcaggg cttccagagc 2341 aggataggat ggcaatgacc cttcccagga actgccagag gtccaaactc cagctggaaa 2401 ggacagtgtc cacctcttct cagccagaag agaatgtgga cagggccaat gacatgcttc 2461 caaaaaaatc agaggaaagt gctgctccaa gcagggagag accaaaagcc aagttattgc 2521 ccagaggagc cacagctctt cctctcagaa caccctctgg ggatctagcc attacagaga 2581 aggaccctcc aggggtggga gtggctggag tggcagctgc ccccaagggt aaagagaaga 2641 atggtggggc acgacttggg atggctggag ttccagagga tggagagcag ccgggctggc 2701 cttctccagc caaggctgcc cccgtcctcc caaccactca caaccacaaa gtgccagtcc 2761 ttatctcacc cactctgaaa cacactccag ctgacgtgca gctcattggc acagactctc 2821 aggggaataa attcaagctc ttatctgagc atcaggtcac atcctctgga gacaaggacc 2881 gaccccgacg ggtaaaacca aagtgtgccc cacccccacc accagtgatg agactactgc 2941 agcatccgtc catctgctca gaccctacag aagagccaac tgccctaact gcaggacagt 3001 ccacatcaga aacacaggaa ggaggaaaga aggcagctct gggcgcagtg cccatcagtg 3061 ggaaagctgg gaggccagtg atgcctccac ctcaagtgcc tctgcccaca tcttccatct 3121 cgccagccaa aatggccaat ggcacagcag gtactaaagt ggctctgaga aaaaccaaac 3181 aggccgctga gaaaatctca gcagacaaaa tcagcaaaga ggccctgctg gaatgtgctg 3241 acctactgtc cagtgcactc acggaacctg tgcccaacag ccagctggta gacactggac 3301 accagctgct tgactactgc tcaggctatg tggactgcat ccctcaaact cgcaacaaat 3361 ttgccttccg agaggctgtg agcaaactgg aactcagcct gcaggagcta caggtttctt 3421 cagcagctgc tggtgtgccc gggacaaacc ctgtccttaa taacttattg tcatgtgtac 3481 aggaaatcag tgatgtggtg cagaggttgc caactttctt gtacaaagtt ggcattataa 3541 gaaagcattg cttatcaatt tgttgcaacg aac